通过实时 FRET 显微镜和免疫荧光评估早期斑马鱼 Noonan 综合征模型中 ERK 活性调节的有效方案

Overview

This study presents an in vivo protocol utilizing zebrafish to investigate RASopathy-associated ERK activation levels through live FRET imaging. The approach aims to validate pathogenic variants and assess pharmacological modulation during embryogenesis.

Key Study Components

Area of Science

• Neuroscience
• Genetics
• Developmental Biology

Background

• RASopathies are genetic syndromes linked to RAS-MAPK pathway hyperactivation.
• Emerging variants require validation for effective therapy development.
• Current preclinical evidence is limited, necessitating improved models.
• Live FRET imaging offers a novel approach to study ERK activation in vivo.

Purpose of Study

• To test RASopathy-associated ERK activation levels in zebrafish.
• To validate potentially pathogenic variants linked to RASopathies.
• To explore pharmacological modulation during embryogenesis.

Methods Used

• Generation of zebrafish models for complex developmental diseases.
• Linking patient sequencing data to functional genomics.
• Microinjection of fertilized zebrafish eggs with custom materials.
• Utilization of FRET sensors for detecting Ras-MAPK signaling changes.

Main Results

• Successful alignment and injection of zebrafish eggs for experimental consistency.
• Demonstration of spatiotemporal sensitivity in detecting ERK activation.
• Validation of the in vivo assay for assessing pathogenic changes.
• Potential for improved preclinical drug testing methodologies.

Conclusions

• The study provides a robust framework for investigating RASopathies.
• Live FRET imaging is a promising tool for real-time analysis of signaling pathways.
• Future research can build on these findings to enhance therapeutic strategies.

Frequently Asked Questions